Natera Inc NTRA:NASDAQ

Last Price$114.93NASDAQ Previous Close - Last Trade as of 4:00PM ET 10/22/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$109.01 (125)
Ask (Size)$121.05 (25)
Day Low / HighN/A - N/A
Volume561.6 K
 

View Medical/Nursing Services IndustryPeer Comparison as of 10/22/2021

 

Natera Inc ( NASDAQ )

Price: $114.93
Change: +2.61 (2.32%)
Volume: 561.6 K
4:00PM ET 10/22/2021
 
 

Acceleron Pharma Inc ( NASDAQ )

Price: $173.95
Change: +0.20 (0.12%)
Volume: 196.9 K
4:00PM ET 10/22/2021
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Novavax Inc ( NASDAQ )

Price: $134.56
Change: -4.23 (3.05%)
Volume: 3.1 M
4:00PM ET 10/22/2021
 
 

Mirati Therapeutics Inc ( NASDAQ )

Price: $190.29
Change: +12.99 (7.33%)
Volume: 581.9 K
4:00PM ET 10/22/2021
 

Read more news Recent News

Insider Sell: Natera
9:32AM ET 10/06/2021 MT Newswires

Steven Leonard Chapman, Director, CEO AND PRESIDENT, on October 02, 2021, sold 21,157 shares in Natera (NTRA) for $2,288,781. Following the Form 4 filing...

Insider Sell: Natera
10:01AM ET 9/30/2021 MT Newswires

Michael Burkes Brophy, CHIEF FINANCIAL OFFICER, on September 27, 2021, sold 25,947 shares in Natera (NTRA) for $2,974,936. Following the Form 4 filing with...

Insider Sell: Natera
9:33AM ET 9/27/2021 MT Newswires

Steven Leonard Chapman, Director, CEO AND PRESIDENT, on September 22, 2021, sold 28,563 shares in Natera (NTRA) for $3,411,189. Following the Form 4 filing...

Insider Sell: Natera
8:05AM ET 9/13/2021 MT Newswires

Steven Leonard Chapman, Director, CEO AND PRESIDENT, on September 09, 2021, sold 90,968 shares in Natera (NTRA) for $10,890,042. Following the Form 4...

Company Profile

Business DescriptionNatera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA. View company web site for more details
Address13011 McCallen Pass
Austin, Texas 78753
Phone+1.650.249.9090
Number of Employees975
Recent SEC Filing09/13/20214
President, Chief Executive Officer & DirectorStephen Chapman
Chief Operating OfficerRobert A. Schueren
Chief Financial OfficerMichael Burkes Brophy
Chief Medical Officer & Senior VP-Medical AffairsPaul R. Billings

Company Highlights

Price Open$112.28
Previous Close$112.32
52 Week Range$65.61 - 129.09
Market Capitalization$10.8 B
Shares Outstanding93.8 M
SectorHealth Services
IndustryMedical/Nursing Services
Next Earnings Announcement11/04/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.66
Beta vs. S&P 500N/A
Revenue$257.7 M
Net Profit Margin-62.32%
Return on Equity-74.30%

Analyst Ratings as of 09/07/2021

Buy
8
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset